FDX1 and colon adenocarcinoma: Interestingly, one report has uncovered that the expression of FDX1 in colon adenocarcinoma (COAD) tissues is significantly lower than that in normal tissues, and the overall survival rate of COAD patients with FDX1 high expression group is better than that in patients with FDX1 low expression (Wang et al. 2022).